X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JAMA Oncology

期刊標題檢索 JAMA ONCOL 最新評論: Have you sent it for external review? (2024-07-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JAMA Oncology]您好,您是該頁面的第 28793 位訪客。

期刊簡介
期刊名稱JAMA Oncology JAMA Oncology
LetPub Score
9.4
50 ratings
Rate

Reputation
10.0

Influence
9.4

Speed
7.0

期刊簡稱JAMA ONCOL
ISSN2374-2437
E-ISSN2374-2445
h-index61
CiteScore
CiteScoreSJRSNIPCiteScore Rank
37.507.8435.394
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q110 / 404
Category: Medicine
Subcategory: Cancer Research
Q17 / 230

自引率 (2023-2024)1.30%自引率趨勢
掲載範囲
JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
官方網站https://jamanetwork.com/journals/jamaoncology
在線稿件提交https://manuscripts.jamaonc.com/cgi-bin/main.plex
開放訪問No
出版商American Medical Association
主題領域Medicine
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數132每年文章數趨勢
黃金OA百分比24.40%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ112/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2374-2437%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【JAMA Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature CancerH-index: 0

    CiteScore: 31.10
    JAMA OncologyH-index: 41

    CiteScore: 37.50
    Trends in CancerH-index: 0

    CiteScore: 28.50
    Liver CancerH-index: 25

    CiteScore: 20.80
    Experimental Hematology & OncologyH-index: 0

    CiteScore: 12.60
    ESMO OpenH-index: 0

    CiteScore: 11.70
    Cancer Biology & MedicineH-index: 29

    CiteScore: 9.80
    Annual Review of Cancer BiologyH-index: 0

    CiteScore: 14.50
    CancersH-index: 53

    CiteScore: 8.00
    Translational Lung Cancer ResearchH-index: 0

    CiteScore: 7.20
    學科內最受檢索的期刊 頁面查看次數
    Cancers209506
    OncoTargets and Therapy183286
    Cancer Management and Research149109
    Journal of Oncology88245
    Cancer Biology & Medicine58478
    Molecular Therapy-Oncolytics43576
    JAMA Oncology36961
    Liver Cancer34135
    Nature Cancer33325
    Translational Lung Cancer Research29416
  •  

    JAMA Oncology JAMA Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [JAMA Oncology] 的評論撰寫評論
作者: 南琴少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-31 20:26:47 評論於
Have you sent it for external review?
(0) 讚! | 南琴少女

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-28 11:19:26 評論於
Under review for 9 days
(0) 讚! | 西域妙绿

作者: 西域妙绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 15:35:00 評論於
Soft heart editor, soft heart reviewer
(0) 讚! | 西域妙绿

作者: 北风爱梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-02 16:24:27 評論於
About three months
(0) 讚! | 北风爱梅

作者: 西行寺继芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-01 20:44:25 評論於
Shouldn't the editor generally invite the original author to reply after accepting the comment? It takes so long, does anyone know?
(0) 讚! | 西行寺继芳

作者: 西行寺继芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-01 17:45:33 評論於
How long does the proof take to come out?
(0) 讚! | 西行寺继芳

作者: 桃花玉萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-25 20:12:07 評論於
What's next? Any opinions?
(0) 讚! | 桃花玉萍

作者: 百花雅彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 15:47:47 評論於
I also recorded the reckless probing, P
(0) 讚! | 百花雅彤

作者: Pearl FitzGerald


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-11 13:07:18 評論於
Thank you, thank you, thank you teacher!
(0) 讚! | Pearl FitzGerald

作者: 碧桃米阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-10 14:09:53 評論於
There is no "with editor" status, it will show as "under review". Generally, if it takes more than a week, it means it has been sent out for external review. Good luck!
(0) 讚! | 碧桃米阳

作者: Pearl FitzGerald


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-08 22:37:13 評論於
Please, may I ask if you are going to provide a brief report or a letter?
(0) 讚! | Pearl FitzGerald

作者: Pearl FitzGerald


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-08 11:02:02 評論於
Teacher, may I ask if the "Under review" status for this journal actually means it is under external review? I checked it for two days and it suddenly changed to "Under review." Is there hope for acceptance, or has it just been reviewed by the editor?
(0) 讚! | Pearl FitzGerald

作者: 碧桃米阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-19 15:36:02 評論於
If there is no rejection for more than 1 week, it is basically an external audit, and there is no change in status
(0) 讚! | 碧桃米阳

作者: 碧桃米阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-19 12:16:31 評論於
Well
(0) 讚! | 碧桃米阳

作者: 以琴大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-18 23:40:10 評論於
How do I know if I need to submit this for an external review?
(0) 讚! | 以琴大叔

作者: 混元新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-18 09:57:26 評論於
Now all articles need to be reviewed externally
(0) 讚! | 混元新曦

作者: 碧桃米阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-27 22:43:15 評論於
Review speed: 3.0 | Submission hit rate: 5.0
Research focus: tumor
Experience sharing: Sharing the submission experience of JAMA Oncology, the efficiency of the top journal is high, with quick responses. Wishing everyone a smooth submission process!
2022.8.7 submit
2022.8.7 QC
2022.8.8 Under review
2022.10.10 Reminder
2022.10.11 Email reply is waiting for the opinion of the third reviewer
2022.11.04 First round result - revision Three reviewers provided many detailed comments, giving overall positive evaluations. The editor finally gave 2-3 weeks for revision, with a one-week extension requested.
2022.11.04 - 11.30 Modify the article + polish
2022.12.01 R1 resubmit
2022.12.01 QC
2022.12.02 Under review
2023.1.10 accept! Wishing everyone smooth acceptance of their submitted articles in the end!
(0) 讚! | 碧桃米阳

作者: 北风爱梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-17 13:08:54 評論於
Review speed: 1.0 | Submission acceptance rate: 75.0 Experience sharing: Hi experts, I have a question regarding this journal. How long does it take for proofs to be released after submitting a letter?
(0) 讚! | 北风爱梅

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 21:52:08 評論於
It is highly unlikely unless the design implementation is extremely rigorous
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 13:36:29 評論於
No charge
(0) 讚! | 是志丹吖

作者: 东海春兴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 08:03:38 評論於
Two days after submission, the corresponding author received an email
(0) 讚! | 东海春兴

作者: 东海春兴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-22 09:56:53 評論於
Focused research area: lung cancer; Oncology
Experience sharing: Have you received the email from the journal after submitting your manuscript?
(0) 讚! | 东海春兴

作者: 洺华小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-19 23:49:24 評論於
Could you please tell me, is the review time fast?
(0) 讚! | 洺华小仙女

作者: 心水小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-18 16:42:01 評論於
Can you take a case? Any experienced masters available? ?
(0) 讚! | 心水小哥哥

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:57:20 評論於
Most journals use online submission for manuscripts. Authors need to prepare the manuscript, figures, and other data in advance. The submission process generally involves visiting the journal's website, opening the "submit paper" section, registering an account as the corresponding author, logging in as an author, following the prompts to complete the submission, downloading the PDF, ensuring accuracy, and then submitting
(0) 讚! | 维尔娜菲茨杰拉德

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [JAMA Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*